Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
J Clin Neurol ; 19(6): 530-538, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37455507

ABSTRACT

BACKGROUND AND PURPOSE: While the clinical hallmarks of transient global amnesia (TGA) are well defined, its pathophysiological causes are poorly understood. Specifically, risk factors for recurrences are yet to be determined. METHODS: This retrospective study analyzed TGA cases diagnosed and treated within the TEMPiS telestroke network and a university stroke center in Germany. Demographic and clinical data were assessed and characteristics of TGA episodes were recorded, such as season of occurrence, trigger factors, duration, and concomitant symptoms. Follow-up of the potential recurrence of TGA was performed using a standardized questionnaire. RESULTS: Overall 109 patients were included (age 64±8 years [mean±SD], 59.6% female). The most common vascular risk factor was arterial hypertension (60.6%), and other concomitant conditions included migraine (11.9%), hypothyroidism (22.9%), and atrial fibrillation (4.6%). The most frequent concomitant clinical feature accompanying the TGA episode at admission was elevated blood pressure (48.6%). Nineteen patients experienced at least one recurrent TGA episode. Migraine and hypothyroidism were only observed in subjects with a single TGA episode without recurrence (migraine: 14.4% without recurrence vs. none in the recurrence group, p=0.02; hypothyroidism: 27.8% without recurrence vs. none in the recurrence group, p=0.009). In contrast, atrial fibrillation was more common in subjects with TGA recurrence (p<0.001). CONCLUSIONS: Arterial hypertension is prevalent in TGA patients, with elevated blood pressure being the most-frequent concomitant condition. In our cohort, recurrence of TGA occurred in approximately one-fifth of patients. Concomitant conditions such as migraine, hypothyroidism, and atrial fibrillation occurred at different frequencies in the two groups.

2.
Environ Monit Assess ; 195(1): 62, 2022 Nov 03.
Article in English | MEDLINE | ID: mdl-36326929

ABSTRACT

Bottled water is becoming more popular worldwide and possible contamination's need to be analyzed. Microplastics (MPs) are ubiquitous environmental pollutants and have recently been regarded as an important contaminant in bottled water due to oral intake and possible threats to human health. In the present study, MP amounts in 23 popular Iranian brands of bottled water were determined by filtration and counting under scanning electron microscopy (SEM). The effects of mechanical stress, environmental factors, and freezing on MP release also were investigated. The average amounts of MPs in water samples were 1496.7 ± 1452.2 particles/L (199.8 to 6626.7 particles/L). The amounts of MPs in different brands was significantly different (p < 0.05). As much as 91.3% of detected particles had the size between 1 and 10 µm. The most likely polymers determined by FTIR spectroscopy was polyethylene terephthalate (PET). The freezing of water in the bottles did not show any significant effect on the MPs release, but mechanical stress to the bottles increased MP amounts in the water significantly. Environmental factors including sunlight exposure and the age of bottles showed the most degradative effects on the structure of polymers in the body of PET bottles and release of MPs. Regardless of their type, source and commercial brands, bottled water is contaminated with hundreds to thousands MPs/L. The main portion (above 90%) of these MPs are < 5 µm particles with considerable effects on human health.


Subject(s)
Drinking Water , Water Pollutants, Chemical , Humans , Drinking Water/chemistry , Microplastics , Plastics , Sunlight , Stress, Mechanical , Freezing , Iran , Environmental Monitoring , Water Pollutants, Chemical/analysis , Polyethylene Terephthalates/chemistry
3.
Praxis (Bern 1994) ; 111(6): 358-361, 2022 Apr.
Article in German | MEDLINE | ID: mdl-35473321

ABSTRACT

Memory Loss - a Case of Sudden Amnesia Abstract. Transient global amnesia (TGA) is a clinical diagnosis with typical signs of an anterograde and retrograde amnesia. The underlying mechanisms are yet unknown, different hypotheses are being discussed. Ultimately there is a temporary dysfunction of the hippocampi. Consistent with this, transient uni- or bilateral punctiform hyperintense lesions may be found on DWI-MRI sequences, usually without correlation on FLAIR-weighthed MR-images. Symptoms usually resolve within twenty-four hours. There is no need for a specific therapy. A prophylactic therapy, such as antithrombotic treatment, is not indicated. The prognosis is usually good, the risk of a recurrence is about 18%.


Subject(s)
Amnesia, Transient Global , Amnesia , Amnesia/etiology , Amnesia/pathology , Amnesia, Transient Global/diagnosis , Amnesia, Transient Global/etiology , Amnesia, Transient Global/pathology , Diffusion Magnetic Resonance Imaging , Hippocampus/diagnostic imaging , Hippocampus/pathology , Humans , Memory Disorders
4.
Eur J Neurol ; 29(3): 732-743, 2022 03.
Article in English | MEDLINE | ID: mdl-34845794

ABSTRACT

BACKGROUND: Most case series of patients with ischemic stroke (IS) and COVID-19 are limited to selected centers or lack 3-month outcomes. The aim of this study was to describe the frequency, clinical and radiological features, and 3-month outcomes of patients with IS and COVID-19 in a nationwide stroke registry. METHODS: From the Swiss Stroke Registry (SSR), we included all consecutive IS patients ≥18 years admitted to Swiss Stroke Centers or Stroke Units during the first wave of COVID-19 (25 February to 8 June 2020). We compared baseline features, etiology, and 3-month outcome of SARS-CoV-2 polymerase chain reaction-positive (PCR+) IS patients to SARS-CoV-2 PCR- and/or asymptomatic non-tested IS patients. RESULTS: Of the 2341 IS patients registered in the SSR during the study period, 36 (1.5%) had confirmed COVID-19 infection, of which 33 were within 1 month before or after stroke onset. In multivariate analysis, COVID+ patients had more lesions in multiple vascular territories (OR 2.35, 95% CI 1.08-5.14, p = 0.032) and fewer cryptogenic strokes (OR 0.37, 95% CI 0.14-0.99, p = 0.049). COVID-19 was judged the likely principal cause of stroke in 8 patients (24%), a contributing/triggering factor in 12 (36%), and likely not contributing to stroke in 13 patients (40%). There was a strong trend towards worse functional outcome in COVID+ patients after propensity score (PS) adjustment for age, stroke severity, and revascularization treatments (PS-adjusted common OR for shift towards higher modified Rankin Scale (mRS) = 1.85, 95% CI 0.96-3.58, p = 0.07). CONCLUSIONS: In this nationwide analysis of consecutive ischemic strokes, concomitant COVID-19 was relatively rare. COVID+ patients more often had multi-territory stroke and less often cryptogenic stroke, and their 3-month functional outcome tended to be worse.


Subject(s)
COVID-19 , Ischemic Stroke , Stroke , Humans , Registries , SARS-CoV-2 , Stroke/epidemiology , Stroke/therapy , Switzerland/epidemiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...